Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

10.91

-0.25 (-2.24%)

At close: Aug 1, 2025, 4:00 PM

10.90

-0.01 (-0.09%)

After-hours: Aug 1, 2025, 4:04 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Human Therapeutics	64.38M	Log In	Log In	Log In	Log In	Upgrade
Human Therapeutics Growth	12.12%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	64.38M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	12.55%	Log In	Log In	Log In	Log In	Upgrade
Europe	-	Log In	Log In	Log In	Log In	Upgrade
Europe Growth	-	Log In	Log In	Log In	Log In	Upgrade